Blood marker trends may sharpen liver cancer prognosis
NCT ID NCT07204262
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 21 times
Summary
This study looked at 379 people with liver cancer to see if monitoring changes in blood markers over time, along with standard clinical information, could better predict how the disease will progress. The goal was to create a more accurate tool for doctors to personalize treatment decisions. The study did not test a new treatment but focused on improving risk assessment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shenzhen Third People's Hospital
Shenzhen, Guangdong, 518112, China
Conditions
Explore the condition pages connected to this study.